APA (7th ed.) Citation

Baraliakos, X., Bessette, L., de Vlam, K., Taylor, P. C., Biljan, A., Urbanik, J., . . . Magrey, M. (2026). Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis of the Phase 2/3 SELECT-AXIS Studies. Rheumatology & Therapy, 13(3), 611. https://doi.org/10.1007/s40744-026-00834-5

Chicago Style (17th ed.) Citation

Baraliakos, Xenofon, et al. "Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis of the Phase 2/3 SELECT-AXIS Studies." Rheumatology & Therapy 13, no. 3 (2026): 611. https://doi.org/10.1007/s40744-026-00834-5.

MLA (9th ed.) Citation

Baraliakos, Xenofon, et al. "Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis of the Phase 2/3 SELECT-AXIS Studies." Rheumatology & Therapy, vol. 13, no. 3, 2026, p. 611, https://doi.org/10.1007/s40744-026-00834-5.